A detailed history of Parallel Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Parallel Advisors, LLC holds 72,087 shares of JNJ stock, worth $11.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
72,087
Previous 79,551 9.38%
Holding current value
$11.2 Million
Previous $12.6 Million 16.27%
% of portfolio
0.27%
Previous 0.34%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$144.38 - $157.78 $1.08 Million - $1.18 Million
-7,464 Reduced 9.38%
72,087 $10.5 Million
Q1 2024

May 06, 2024

BUY
$155.22 - $162.74 $1.78 Million - $1.86 Million
11,447 Added 16.81%
79,551 $12.6 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $985,129 - $1.07 Million
-6,766 Reduced 9.04%
68,104 $10.7 Million
Q3 2023

May 20, 2024

BUY
$155.75 - $174.48 $353,552 - $396,069
2,270 Added 3.13%
74,870 $11.7 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $353,552 - $396,069
2,270 Added 3.13%
74,870 $11.7 Million
Q2 2023

May 20, 2024

BUY
$154.35 - $166.11 $749,832 - $806,962
4,858 Added 7.17%
72,600 $12 Million
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $749,832 - $806,962
4,858 Added 7.17%
72,600 $12 Million
Q1 2023

May 20, 2024

SELL
$151.05 - $180.26 $1.78 Million - $2.13 Million
-11,809 Reduced 14.84%
67,742 $10.5 Million
Q1 2023

Apr 25, 2023

BUY
$151.05 - $180.26 $1.38 Million - $1.65 Million
9,151 Added 15.62%
67,742 $10.5 Million
Q4 2022

Feb 03, 2023

BUY
$160.2 - $179.79 $380,154 - $426,641
2,373 Added 4.22%
58,591 $10.4 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $2,097 - $2,333
-13 Reduced 0.02%
56,218 $9.18 Million
Q2 2022

Aug 01, 2022

BUY
$168.19 - $186.01 $727,421 - $804,493
4,325 Added 8.33%
56,231 $9.98 Million
Q1 2022

Apr 28, 2022

BUY
$158.14 - $179.59 $654,541 - $743,323
4,139 Added 8.66%
51,906 $9.32 Million
Q4 2021

Jan 20, 2022

SELL
$155.93 - $173.01 $250,267 - $277,681
-1,605 Reduced 3.25%
47,767 $8.17 Million
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $625,651 - $695,266
3,874 Added 8.51%
49,372 $7.97 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $943,324 - $1.01 Million
5,915 Added 14.94%
45,498 $7.5 Million
Q1 2021

Apr 23, 2021

BUY
$153.07 - $170.48 $758,308 - $844,557
4,954 Added 14.31%
39,583 $6.51 Million
Q4 2020

Feb 02, 2021

SELL
$137.11 - $157.38 $294,649 - $338,209
-2,149 Reduced 5.84%
34,629 $5.45 Million
Q3 2020

Oct 27, 2020

BUY
$140.38 - $153.83 $49,834 - $54,609
355 Added 0.97%
36,778 $5.48 Million
Q2 2020

Jul 16, 2020

SELL
$128.81 - $155.51 $43,666 - $52,717
-339 Reduced 0.92%
36,423 $5.12 Million
Q1 2020

Apr 27, 2020

BUY
$111.14 - $153.99 $563,035 - $780,113
5,066 Added 15.98%
36,762 $4.82 Million
Q4 2019

Jan 30, 2020

SELL
$127.5 - $146.44 $27,540 - $31,631
-216 Reduced 0.68%
31,696 $4.62 Million
Q3 2019

Nov 01, 2019

BUY
$126.95 - $142.14 $369,551 - $413,769
2,911 Added 10.04%
31,912 $4.13 Million
Q2 2019

Aug 05, 2019

BUY
$131.15 - $144.24 $325,383 - $357,859
2,481 Added 9.36%
29,001 $4.04 Million
Q1 2019

May 01, 2019

SELL
$125.72 - $139.79 $220,261 - $244,912
-1,752 Reduced 6.2%
26,520 $3.71 Million
Q4 2018

Feb 05, 2019

SELL
$122.84 - $147.84 $129,473 - $155,823
-1,054 Reduced 3.59%
28,272 $3.65 Million
Q3 2018

Nov 01, 2018

BUY
$121.58 - $142.88 $246,077 - $289,189
2,024 Added 7.41%
29,326 $4.05 Million
Q2 2018

Jul 30, 2018

BUY
$119.4 - $131.76 $43,461 - $47,960
364 Added 1.35%
27,302 $3.31 Million
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $134,107 - $158,806
-1,072 Reduced 3.83%
26,938 $3.45 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $35,823 - $39,208
273 Added 0.98%
28,010 $3.91 Million
Q3 2017

Nov 15, 2017

BUY
$129.47 - $135.38 $3.59 Million - $3.76 Million
27,737 New
27,737 $3.88 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $3.58 Million - $3.74 Million
-27,660 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
27,660
27,660 $3.67 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.